Clinical Trial Results TV
Trial / Study: 1154 submissions (showing 1 to 15)

| Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 | Page 17 | Page 18 | Page 19 | Page 20 | Page 21 | Page 22 | Page 23 | Page 24 | Page 25 | Page 26 | Page 27 | Page 28 | Page 29 | Page 30 | Page 31 | Page 32 | Page 33 | Page 34 | Page 35 | Page 36 | Page 37 | Page 38 | Page 39 | Page 40 | Page 41 | Page 42 | Page 43 | Page 44 | Page 45 | Page 46 | Page 47 | Page 48 | Page 49 | Page 50 | Page 51 | Page 52 | Page 53 | Page 54 | Page 55 | Page 56 | Page 57 | Page 58 | Page 59 | Page 60 | Page 61 | Page 62 | Page 63 | Page 64 | Page 65 | Page 66 | Page 67 | Page 68 | Page 69 | Page 70 | Page 71 | Page 72 | Page 73 | Page 74 | Page 75 | Page 76 | Page 77 |

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Carolyn Lam and Dr. C. Michael Gibson Discuss How to Initiate Heart Failure Drugs
Dr. Carolyn Lam

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss Shockwave FDA Approval
Dr. Dean Kereiakes

1 Star 2 Star 3 Star 4 Star 5 Star
Heart Success: Dr. Carolyn Lam and Dr. C. Michael Gibson Talk About Success in the Battle Against Heart Failure
Dr. Carolyn Lam

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. John Teerlink and Dr. C. Michael Gibson Discuss: Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection F
Dr. John Teerlink

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Robert Harrington and Dr. C. Michael Gibson Discuss: The AHA COVID-19 Cardiovascular Disease Registry: Design, Imple
Dr. Robert Harrington

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Deepak Bhatt and C. Michael Gibson Discuss: The SOLOIST-WHF and SCORED Trials: Sotagliflozin in Diabetes Patients
Dr. Deepak Bhatt

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Deepak Bhatt and C. Michael Gibson Discuss: Divergent Results in the STRENGTH and REDUCE-IT trials
Dr. Deepak Bhatt

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: AHA 2020 Daily Wrap-Up - November 16, 2020
Dr. Roxana Mehran

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Steven Steinhubl and Dr. C. Michael Gibson Discuss: 3-year Clinical Outcomes In A Nationwide, Randomized, Pragmatic
Dr. Steven R. Steinhubl

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. A. Michael Lincoff and Dr. C. Michael Gibson Discuss: STRENGTH Trial: Cardiovascular Outcomes With Omega-3 Carboxyli
Dr. A. Michael Lincoff, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Prem Pais and Dr. Serge Korjian Discuss: A Polypill For Primary Prevention Of Cardiovascular Disease In Intermediate
Dr. Prem Pais

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Salim Yusuf and Dr. C. Michael Gibson Discuss: Aspirin Alone And In Combination With A Polypill In Cardiovascular Di
Dr. Salim Yusuf

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Renato Lopes and Dr. C. Michael Gibson Discuss: Rivaroxaban Versus Warfarin In Patients With Bioprosthetic Mitral Va
Dr. Renato Lopes

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Otavio Berwanger and Dr. C. Michael Gibson Discuss: Rivaroxaban Versus Warfarin In Patients With Bioprosthetic Mitra
Dr. Otavio Berwanger

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Robert Byrne and Dr. C. Michael Gibson Discuss: COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Co
Dr. Robert Byrne